HTLV-1 drives vigorous clonal expansion of infected CD8+ T cells in natural infection

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Melamed, Anat ^a   Laydon, Daniel J ^a   Al Khatib, Hebah ^a   Rowan, Aileen G ^a   Taylor, Graham P ^a   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Clonality; Cytotoxic T cells; HTLV 1; Human retroviral infection; Integration; Latency

Indexed keywords

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; LEUKEMOGENESIS; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; T CELL LEUKEMIA; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; ADULT; CELL CLONE; CYTOTOXIC T LYMPHOCYTE; HIGH THROUGHPUT SEQUENCING; HTLV-1 INFECTION; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY; PROVIRUS; VIROLOGY; VIRUS LATENCY;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PROVIRUSES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; VIRUS INTEGRATION; VIRUS LATENCY;

EID: 84946568384     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0221-1     Document Type: Article

References (47)

1. Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388. doi: 10.3389/fmicb.2012.00388.
2. Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, et al. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 2001;7(3):228-34. doi: 10.1080/13550280152403272.
3. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211-9. doi: 10.1182/blood-2009-12-257410.
4. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990;64(11):5682-7.
5. Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood. 2001;98(6):1858-61. doi: 10.1182/blood.V98.6.1858.
6. Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, Lisinski I, et al. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol. 2006;80(17):8291-302. doi: 10.1128/JVI.00389-06.
7. Kannian P, Yin H, Doueiri R, Lairmore MD, Fernandez S, Green PL. Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol. 2012;86(7):3757-66. doi: 10.1128/JVI.06900-11.
8. Hattori T, Uchiyama T, Toibana T, Takatsuki K, Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood. 1981;58(3):645-7.
9. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27(3):453-9. doi: 10.1200/JCO.2008.18.2428.
10. Mahieux R, Gessain A. Adult T-cell leukemia/lymphoma and HTLV-1. Curr Hematol Malig Reports. 2007;2(4):257-64. doi: 10.1007/s11899-007-0035-x.
11. Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13(5):657-64.
12. Popovic M, Flomenberg N, Volkman DJ, Mann D, Fauci AS, Dupont B, et al. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science. 1984;226(4673):459-62.
13. Mitsuya H, Jarrett RF, Cossman J, Cohen OJ, Kao CS, Guo HG, et al. Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I. J Clin Invest. 1986;78(5):1302-10. doi: 10.1172/JCI112715.
14. + cytotoxic T-cell clones results in immortalization with retention of antigen specificity. J Virol. 1988;62(8):2942-50.
15. Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117(11):3113-22. doi: 10.1182/blood-2010-10-312926.
16. Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L, et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood. 2014;123(25):3925-31. doi: 10.1182/blood-2014-02-553602.
17. Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, et al. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS Pathog. 2013;9(4):e1003263. doi: 10.1371/journal.ppat.1003263.
18. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CR. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013;9(3):e1003271. doi: 10.1371/journal.ppat.1003271.
19. Niederer HA, Laydon DJ, Melamed A, Elemans M, Asquith B, Matsuoka M, et al. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP. Virol J. 2014;11:172. doi: 10.1186/1743-422X-11-172.
20. Melamed A, Witkover AD, Laydon DJ, Brown R, Ladell K, Miners K, et al. Clonality of HTLV-2 in natural infection. PLoS Pathog. 2014;10(3):e1004006. doi: 10.1371/journal.ppat.1004006.
21. Gillet NA, Gutierrez G, Rodriguez SM, de Brogniez A, Renotte N, Alvarez I, et al. Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog. 2013;9(10):e1003687. doi: 10.1371/journal.ppat.1003687.
22. Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 2014;345(6193):179-83. doi: 10.1126/science.1254194.
23. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood. 2012;120(17):3488-90. doi: 10.1182/blood-2012-07-445593.
24. Laydon DJ, Melamed A, Sim A, Gillet NA, Sim K, Darko S, et al. Quantification of HTLV-1 clonality and TCR diversity. PLoS Comput Biol. 2014;10(6):e1003646. doi: 10.1371/journal.pcbi.1003646.
25. Kamihira S, Sohda H, Atogami S, Toriya K, Yamada Y, Tsukazaki K, et al. Phenotypic diversity and prognosis of adult T-cell leukemia. Leuk Res. 1992;16(5):435-41.
26. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology. 1993;196(1):25-33.
27. Filion LG, Izaguirre CA, Garber GE, Huebsh L, Aye MT. Detection of surface and cytoplasmic CD4 on blood monocytes from normal and HIV-1 infected individuals. J Immunol Methods. 1990;135(1-2):59-69.
28. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95(4):1386-92.
29. + cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J Virol. 1996;70(2):843-51.
30. + lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol. 2000;102(2):208-15.
31. Wodarz D, Hall SE, Usuku K, Osame M, Ogg GS, McMichael AJ, et al. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci/The Royal Soc. 2001;268(1473):1215-21. doi: 10.1098/rspb.2001.1608.
32. Sibon D, Gabet AS, Zandecki M, Pinatel C, Thete J, Delfau-Larue MH, et al. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest. 2006;116(4):974-83. doi: 10.1172/JCI27198.
33. Tomasetti C, Vogelstein B. Cancer etiology Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015;347:78-81. doi: 10.1126/science.1260825.
34. Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci USA. 2001;98(25):14559-64. doi: 10.1073/pnas.251540598.
35. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci USA. 1998;95(5):2452-7.
36. Mariner JM, Lantz V, Waldmann TA, Azimi N. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol. 2001;166(4):2602-9.
37. Azimi N, Jacobson S, Leist T, Waldmann TA. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol. 1999;163(7):4064-72.
38. + memory T cells by opposing cytokines. Science. 2000;288(5466):675-8. doi: 10.1126/science.288.5466.675.
39. + T cells: frequency and immunodominance hierarchy. J Infect Dis. 2004;189(12):2294-8. doi: 10.1086/420832.
40. + T-lymphocyte responses that correlate with clinical outcome. J Infect Dis. 2011;203(4):529-36. doi: 10.1093/infdis/jiq078.
41. Koenig S, Woods RM, Brewah YA, Newell AJ, Jones GM, Boone E, et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 1993;151(7):3874-83.
42. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993;177(6):1567-73.
43. + T cells in human T lymphotropic virus type 2 infection. J Immunol. 2009;183(5):2957-65. doi: 10.4049/jimmunol.0900508.
44. Bangham CR, Cook LB, Melamed A. HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection. Semin Cancer Biol. 2014;26:89-98. doi: 10.1016/j.semcancer.2013.11.003.
45. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: Lyon: International Agency for Research on Cancer; 2008.
46. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
47. Handcock MS, Morris M. Relative distribution methods in the social sciences. Statistics for social science and public policy. New York: Springer; 1999.